These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1358572)

  • 21. Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat.
    Patel DK; Woolley JL; Shcokcor JP; Johnson RL; Taylor LC; Sigel CW
    Drug Metab Dispos; 1991; 19(2):491-7. PubMed ID: 1676660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
    He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
    Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
    Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and excretion of ropivacaine in humans.
    Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
    Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P; Manna VK; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition of flavodilol in laboratory animals.
    Coan M; Simmons R
    Drug Metab Dispos; 1989; 17(4):420-5. PubMed ID: 2571483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption, distribution, metabolism, and excretion of dirlotapide in the dog.
    Merritt DA; Bessire AJ; Vaz AD; Sams JP; Lynch MP
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():17-23. PubMed ID: 17567511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disposition and metabolism of [14C]piritrexim in dogs after intravenous and oral administration.
    Woolley JL; Deangelis DV; Grace ME; Liao SH; Crouch RC; Sigel CW
    Drug Metab Dispos; 1991; 19(6):1139-46. PubMed ID: 1687022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
    Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
    Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma.
    Berlin J; King AC; Tutsch K; Findlay JW; Kohler P; Collier M; Clendeninn NJ; Wilding G
    Invest New Drugs; 1994; 12(2):137-41. PubMed ID: 7860231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acrivastine: a review of its dermatopharmacology and clinical activity.
    Gibson JR; Manna VK; Salisbury J
    J Int Med Res; 1989; 17 Suppl 2():28B-34B. PubMed ID: 2475374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and bioavailability of acyclovir in the dog.
    Krasny HC; de Miranda P; Blum MR; Elion GB
    J Pharmacol Exp Ther; 1981 Feb; 216(2):281-8. PubMed ID: 7463350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.